发布求助
文献互助 智能选刊 最新文献

Medicom Conference Report EHA 2023最新文献

筛选
英文 中文
Durable responses for loncastuximab tesirine in relapsed/refractory DLBCL loncastuximab tesirine治疗复发/难治性DLBCL的持久疗效
Medicom Conference Report EHA 2023 Pub Date : 2023-08-02 DOI: 10.55788/b1e8991f
Robert van den Heuvel
{"title":"Durable responses for loncastuximab tesirine in relapsed/refractory DLBCL","authors":"Robert van den Heuvel","doi":"10.55788/b1e8991f","DOIUrl":"https://doi.org/10.55788/b1e8991f","url":null,"abstract":"","PeriodicalId":196013,"journal":{"name":"Medicom Conference Report EHA 2023","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122273453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CARTITUDE-4: Cilta-cel meets expectations in lenalidomide-refractory MM cartitute -4: cilta - cell满足来那度胺难治性MM的预期
Medicom Conference Report EHA 2023 Pub Date : 2023-08-02 DOI: 10.55788/21402cd9
Robert van den Heuvel
{"title":"CARTITUDE-4: Cilta-cel meets expectations in lenalidomide-refractory MM","authors":"Robert van den Heuvel","doi":"10.55788/21402cd9","DOIUrl":"https://doi.org/10.55788/21402cd9","url":null,"abstract":"","PeriodicalId":196013,"journal":{"name":"Medicom Conference Report EHA 2023","volume":"61 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115226815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Encouraging results for low-dose belantamab mafodotin plus nirogacestat in patients with RRMM 低剂量贝兰他单抗马福多汀联合硝格司他治疗RRMM患者的令人鼓舞的结果
Medicom Conference Report EHA 2023 Pub Date : 2023-08-02 DOI: 10.55788/7bd1a9d0
Robert van den Heuvel
{"title":"Encouraging results for low-dose belantamab mafodotin plus nirogacestat in patients with RRMM","authors":"Robert van den Heuvel","doi":"10.55788/7bd1a9d0","DOIUrl":"https://doi.org/10.55788/7bd1a9d0","url":null,"abstract":"","PeriodicalId":196013,"journal":{"name":"Medicom Conference Report EHA 2023","volume":"74 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132129722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mapping healthy HPSC variations to diagnose haematopoietic abnormalities 绘制健康HPSC变异以诊断造血异常
Medicom Conference Report EHA 2023 Pub Date : 2023-08-02 DOI: 10.55788/2b4af45f
Robert van den Heuvel
{"title":"Mapping healthy HPSC variations to diagnose haematopoietic abnormalities","authors":"Robert van den Heuvel","doi":"10.55788/2b4af45f","DOIUrl":"https://doi.org/10.55788/2b4af45f","url":null,"abstract":"","PeriodicalId":196013,"journal":{"name":"Medicom Conference Report EHA 2023","volume":"262 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133531748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Promising data for epcoritamab plus R-CHOP in untreated DLBCL epcoritamab联合R-CHOP治疗未治疗的DLBCL有希望的数据
Medicom Conference Report EHA 2023 Pub Date : 2023-08-02 DOI: 10.55788/d4e8de1e
Robert van den Heuvel
{"title":"Promising data for epcoritamab plus R-CHOP in untreated DLBCL","authors":"Robert van den Heuvel","doi":"10.55788/d4e8de1e","DOIUrl":"https://doi.org/10.55788/d4e8de1e","url":null,"abstract":"","PeriodicalId":196013,"journal":{"name":"Medicom Conference Report EHA 2023","volume":"45 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116572824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Promising data for ziftomenib in relapsed/refractory NPM1-mutated AML ziftomenib治疗复发/难治性npm1突变AML的有希望数据
Medicom Conference Report EHA 2023 Pub Date : 2023-08-02 DOI: 10.55788/6b9934fa
Robert van den Heuvel
{"title":"Promising data for ziftomenib in relapsed/refractory NPM1-mutated AML","authors":"Robert van den Heuvel","doi":"10.55788/6b9934fa","DOIUrl":"https://doi.org/10.55788/6b9934fa","url":null,"abstract":"","PeriodicalId":196013,"journal":{"name":"Medicom Conference Report EHA 2023","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125332907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiotherapy or not in patients with PMBCL after immunochemotherapy? PMBCL患者免疫化疗后是否放疗?
Medicom Conference Report EHA 2023 Pub Date : 2023-08-02 DOI: 10.55788/9cbc4701
Robert van den Heuvel
{"title":"Radiotherapy or not in patients with PMBCL after immunochemotherapy?","authors":"Robert van den Heuvel","doi":"10.55788/9cbc4701","DOIUrl":"https://doi.org/10.55788/9cbc4701","url":null,"abstract":"","PeriodicalId":196013,"journal":{"name":"Medicom Conference Report EHA 2023","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129408935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COMMANDS trial: A paradigm shift in LR-MDS-associated anaemia COMMANDS试验:小mds相关性贫血的范式转变
Medicom Conference Report EHA 2023 Pub Date : 2023-08-02 DOI: 10.55788/24d4d50c
Robert van den Heuvel
{"title":"COMMANDS trial: A paradigm shift in LR-MDS-associated anaemia","authors":"Robert van den Heuvel","doi":"10.55788/24d4d50c","DOIUrl":"https://doi.org/10.55788/24d4d50c","url":null,"abstract":"","PeriodicalId":196013,"journal":{"name":"Medicom Conference Report EHA 2023","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131341300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
QuANTUM-First: Updated results on quizartinib in AML with FLT3-ITD QuANTUM-First: quizartinib治疗FLT3-ITD AML的最新结果
Medicom Conference Report EHA 2023 Pub Date : 2023-08-02 DOI: 10.55788/0739f9c4
Robert van den Heuvel
{"title":"QuANTUM-First: Updated results on quizartinib in AML with FLT3-ITD","authors":"Robert van den Heuvel","doi":"10.55788/0739f9c4","DOIUrl":"https://doi.org/10.55788/0739f9c4","url":null,"abstract":"","PeriodicalId":196013,"journal":{"name":"Medicom Conference Report EHA 2023","volume":"48 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133514180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robust platelet responses with cevidoplenib in ITP cevidoplenib治疗ITP患者血小板反应强劲
Medicom Conference Report EHA 2023 Pub Date : 2023-08-02 DOI: 10.55788/8bf94b46
Robert van den Heuvel
{"title":"Robust platelet responses with cevidoplenib in ITP","authors":"Robert van den Heuvel","doi":"10.55788/8bf94b46","DOIUrl":"https://doi.org/10.55788/8bf94b46","url":null,"abstract":"","PeriodicalId":196013,"journal":{"name":"Medicom Conference Report EHA 2023","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114937482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书